Hosted on MSN3mon
One-time gene therapy reverses liver disease MASH in mouse models
UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more ...
Footwear News on MSN14d
Katy Perry Models Head-to-Toe KNWLS Look to Promote Upcoming Tour and Talk Space Travel on Sirius XM's ‘The Morning Mash Up' in Las Vegas
Katy Perry stopped by The Morning Mash Up at SiriusXM Studios in Las Vegas on Thursday to promote her upcoming "The Lifetimes Tour," which kicks off in Mexico City on April 23. The "Roar" hitmaker ...
EurekAlert!1d
FXR cyclic peptide antagonists as a novel strategy for MASH treatment
In this study, the authors first used an AlphaScreen assay to identify a series of tryptophan-based cyclic peptide compounds with FXR-antagonistic activity, specifically those modified with a ...
EurekAlert!5d
New avenues for treating metabolic dysfunction-associated fatty liver disease
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
BioWorld7d
MASH field still hot as Boehringer axes $870M deal with Yuhan
Boehringer Ingelheim GmbH terminated its second metabolic dysfunction-associated steatohepatitis (MASH) alliance on March 6, ending an $870 million license agreement inked with Yuhan Corp. for dual ...
Unveiling Pharma Market Potential: Delveinsight's Strategic Insights Into The Rapidly Expanding MASH Landscape In Asia
A case study on how DelveInsight helped a pharma client navigate the evolving metabolic dysfunction-associated steatohepatitis (MASH) landsca ...